This study describes the development of 3PO, a nonviral, protein-based gene delivery vector which utilizes the highly evolved cell-binding, cell-entry and intracellular transport functions of the adenovirus serotype 5 (Ad5) capsid penton protein. A penton fusion protein containing a polylysine sequence was produced by recombinant methods and tested for gene delivery capability. As the protein itself is known to bind integrins through a conserved consensus motif, the penton inherently possesses the ability to bind and enter cells through receptor-mediated internalization. The ability to lyse the cellular endosome encapsulating internal-
Introduction
Nonviral methods of gene delivery have remained an attractive alternative to virus-based gene therapy, mainly because of their safety and low toxicity. Their historically low efficiency of gene transfer and expression, particularly in vivo, requires the development of novel strategies to improve delivery. Directing nonviral vectors to cellular receptors by the incorporation of specific ligands, such as transferrin, asialoglycoprotein, or epithelial growth factor (EGF), has provided an efficient means of crossing the plasma membrane by receptor-mediated internalization. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The cellular endosome encapsulating the vector following endocytosis, however, has proven to be a major barrier to nuclear delivery and gene expression by nonviral vectors.
14 Without endosome penetration, lysosomal enzymes eventually degrade the DNA, resulting in low transduction. 15, 16 As viruses have evolved the means to penetrate these barriers, the inclusion of viral fusogenic peptides or endosomolytic agents into nonviral vectors has enhanced the gene delivery capacity of nonviral systems. 12, 17, 18 Attention has been focused on adenovirus capsid proteins for this purpose. It has been shown that the addition of whole, inactivated adenovirus to plasmid conjugates significantly enhances plasmid gene delivery, implying that the adenovirus capsid provides a means for endosomal penetration. [19] [20] [21] [22] As ized receptors is also attributed to the penton. The recombinant protein gains the additional function of DNA binding and transport with the appendage of a polylysine motif. This protein retains the ability to form pentamers and mediates delivery of a reporter gene to cultured cells. Interference by oligopeptides bearing the integrin binding motif suggests that delivery is mediated specifically through integrin receptor binding and internalization. The addition of protamine to penton-DNA complexes allows gene delivery in the presence of serum. Gene Therapy (2001) 8, 795-803.
the next logical step we have attempted to capture this function using only the proteins necessary for imparting cellular uptake and penetration. The highly efficient cell binding and entry functions imparted by the capsid proteins of adenovirus serotype 5 (Ad5) are a major reason why adenoviruses have been widely used as vehicles for gene transfer. 23, 24 The adenovirus capsid is an icosahedral structure with long antenna-like protrusions at each of its 12 vertices. 25 Each protrusion consists of a homotrimeric fiber protein, at the base of which lies a homopentameric penton base. 26, 27 The first step of infection by Ad5 involves high affinity binding of the fiber homotrimer to the Coxsackievirus adenovirus receptor (CAR), a ubiquitous component of mammalian cellular membranes. 28 This is followed by secondary binding of the penton base to ␣ v ␤ 3 and ␣ v ␤ 5 integrins through an Arg-Gly-Asp (RGD) motif located in the middle of the penton protein sequence. [29] [30] [31] Binding of the penton to ␣ v integrins triggers receptor-mediated internalization of the whole virus and subsequent encapsulation into endosomes. 32, 33 Vesicle penetration occurs in response to endosome acidification and appears to be mediated by the penton, thus allowing viral access to the cytoplasm. [34] [35] [36] It has been shown that whereas the fiber receptor fails to internalize in response to ligand binding, ␣ v integrins internalize rapidly after binding to penton proteins. 37 Thus, whereas the binding event that initiates infection by Ad5 is dictated by the fiber, this event is independent of and separable from the secondary binding and subsequent internalization by the penton.
A second integrin binding motif, LDV, is also found in the penton peptide sequence. This core sequence mediates binding to ␣ 4 ␤ 1 and ␣ 4 ␤ 7 integrins, which are predominantly found on lymphocytes, monocytes, and fibroblasts. 38, 39 It has been shown that mutation of this site affects binding to HeLa cells as well, implying that HeLa cells express both ␣ v and ␣ 4 integrins. 36 To explore the use of engineered Ad5 pentons for protein-based gene delivery, soluble proteins were produced by recombinant DNA methods. It has been shown that soluble wild-type penton proteins retain the features of pentamer formation, receptor binding and endocytosis, and assembly with fiber proteins. 27, 37, 40, 41 In order to take advantage of these characteristics for nonviral gene delivery, we have engineered the Ad5 penton protein to bind and transport DNA in the absence of whole virus. In the process of developing this protein for gene therapy, we have tested its ability to mediate gene delivery to cells in culture. Here, we report our in vitro findings.
Results

Characterization of recombinant penton proteins
Previous studies have shown that the appendage of eight to 10 cationic residues to synthetic peptides is adequate for DNA binding. 17 Therefore, we introduced a decalysine sequence at the carboxy (C) terminus of the Ad5 penton protein by genetic modification (Figure 1a) , and recombinant proteins were produced in E. coli. As the lysine tag comprises a short stretch of residues, the predicted molecular size of the modified protein is increased only slightly compared with the unmodified protein. As expected, both lysine-tagged (PBK10) and untagged (PB) penton proteins purified from bacterial lysates similarly migrate near 68 kDa on single percentage gels (Figure 1b , left). On a gradient gel, which better distinguishes the sizes of the two proteins, the lysine-tagged penton exhibits a slightly slower migration rate (Figure 1b, right) , presumably due to both its additional cationic charge and slightly higher molecular weight. Polyclonal antiserum specific to Ad5 capsid proteins recognizes both the lysine-tagged and untagged penton proteins, thus confirming their identities (Figure 1b, right) .
Previous studies using nondenaturing PAGE analysis demonstrated that both viral and recombinant wild-type soluble penton proteins form homopentamers in the absence of additional viral or other scaffolding proteins. 41 We used nondenaturing PAGE to determine the oligomer size formed by PBK10. Under these conditions, PB migrates according to its expected size of approximately 335 kDa (Figure 1c ). PBK10 migrates slower, which is in agreement with homopentamer formation at the predicted size of 345 kDa and its higher cationic charge (Figure 1c) . These results indicate that the additional charged residues at the penton C-terminus do not impede pentamer assembly.
It has been well established that the Ad5 penton binds to ␣ v integrins, which are present on numerous epithelial cell lines, including 293 and HeLa cells. 39 We have previously demonstrated that GFP-tagged proteins can be used to detect receptor-ligand interactions by fluorescence activated cell sorting (FACS). 42 Accordingly, we constructed penton proteins tagged with green fluorescent protein (GFP) at their N-terminus. These proteins were also produced in bacteria and characterized by immunoblotting to confirm their structure (data not shown). We have shown previously that GFP does not interfere with wild-type oligomer formation of ligands. 42 The size of GFP-tagged penton oligomers is difficult to determine, however, as the final product size is too large to assess by standard nondenaturing PAGE analysis. To determine cell binding ability, the GFP-tagged penton proteins were incubated with 293 cells and analyzed by FACS scan. Increasing concentrations of recombinant proteins result in an increased fluorescence emission from treated cells, suggesting dose-dependent cell binding of recombinant proteins (Figure 1d ). Importantly, a similar degree of mean fluorescent shift results from equivalent concentrations of lysine-tagged and untagged proteins, suggesting that the lysine sequence does not interfere with cell binding activity.
PBK10 binds DNA
DNA binding ability can be determined by observing whether bound proteins slow DNA mobility on a gel 797 matrix. To test this, two such assays were performed. In the first assay, an oligonucleotide probe (81 ng) incubated with recombinant proteins exhibits a significant retardation in mobility in the presence of PBK10, but not with similar concentrations of PB or bovine serum albumin (BSA), indicating that DNA binding occurs specifically through the polylysine moiety ( Figure 2a ). The predicted amount of PBK10 to bind all of the probe is 1.75 g, according to the polylysine:DNA phosphate charge ratio. Therefore, 1 g of PBK10 is expected to bind approximately 60% of the probe. Densitometry scanning of the autoradiogram determines that about 70% of the probe is bound by PBK10, which is in close agreement with the predicted requirements. In the second assay, increasing concentrations of PBK10 incubated with constant amounts of plasmid DNA (pGFPemd-cmv) results in a concomitant DNA mobility reduction on an agarose gel ( Figure 2b ). Complete DNA charge neutralization and immobilization of the plasmid DNA would require a PBK10 to DNA (w/w) ratio of 22. In agreement with the predicted ratio, immobilization of the plasmid is achieved at a protein to DNA (w/w) ratio of between 11 and 23. Importantly, the results of both gel shift analyses show that PBK10 can bind both double-stranded circular forms, as well as single-stranded linear DNA.
PBK10 mediates gene delivery into cultured cells
We then tested the ability of PBK10, without the GFP tag, to mediate delivery of plasmid DNA to cells in culture. (Figure 3b ). Equivalent numbers of fluorescent cells are detected in wells treated with either PB + DNA or DNA alone, indicating that PB does not improve GFP expression without the lysine moiety. This suggests that DNA internalization occurs by direct association and transport with the lysine-tagged pentons, and is not an artifact of passive entry with the penton proteins.
To better measure gene delivery, 293 cells treated with penton-DNA complexes were analyzed by FACS. The complexes were formed at ratios selected for their likelihood to neutralize charged polylysine and DNA phosphate (w/w = 22). Cells were exposed to varying molar concentrations of complexes (3, 5, and 15 m PBK10) in serum-free media. At all three PBK10 concentrations, the entire cell population shifts to a higher green fluorescence emission over background ( Figure 4a and trations of PBK10 are required to detect any fluorescence over background. In order to test higher concentrations of PBK10, we first eliminated any free penton oligomers smaller than a pentamer that might compete with PBK10 + DNA complexes for cell binding. Accordingly, 7.5, 15, and 75 m PBK10 or BSA were incubated with constant amounts of DNA before loading the complexes on to ultrafiltration columns that retain molecules greater than 300-900 K molecular weight. Cells were treated in the presence of 1% serum and green fluorescence was measured by FACS 3 days later. At all three doses, there is no detectable fluorescence from BSA-treated cells, whereas PBK10 appears to mediate DNA delivery dose-dependently and produces a significant number of GFP-positive cells (Figure 4b and Table 1 ). At 75 m doses, the visible green fluorescence of PBK10-treated cells is 112-fold over background. In addition, little cytopathic effect is detectable, even at PBK10 concentrations as high as 75 m, suggesting that serum has a protective effect against possible protein-induced cytotoxicity (summarized in Table 1 ). However, at comparative (15 m) concentrations of PBK10, GFP expression is reduced by approximately 80% in the presence of serum. Figure 4c summarizes these FACS results and shows that the presence of 1% serum severely reduces gene delivery and expression.
Protamine protects against serum effects Several factors may produce the extreme reduction in PBK10-mediated gene delivery that is observed in the presence of serum. One of these may be the access of serum nucleases to the DNA, suggesting that PBK10 is unable to fully protect the plasmid DNA from nucleaseinduced damage. The addition of small cationic molecules, such as protamines, might more fully protect the DNA from serum nucleases. Protamines are small, naturally occurring arginine-rich peptides whose interaction with DNA results in phosphate neutralization and DNA collapse. 43, 44 To test the ability of protamine to protect the DNA, we incubated plasmid DNA and increasing concentrations of protamine in the presence of 20% active serum, with or without PBK10 at a standardized protein:DNA ratio (w/w) of 2. Complexes that are sensitive to nuclease activity were detected by the conversion of the plasmid from the supercoiled form to the open circle form, as described elsewhere. 45 Indeed, in the presence of serum alone, nearly all of the plasmid DNA, whether in the presence or absence of PBK10, is converted to nicked forms by 30 min at 37°C (Figure 5a ). However, adding increasing concentrations of protamine preserves supercoiled DNA in the presence of active serum for up to 45 min, thus protecting the plasmid from nucleaseinduced degradation. 
serum-supplemented media (striped bars). Experiments were performed in triplicate, and relative transduction was determined by the percent of GFP-positive cells of treated cell populations over untreated cells. Error bars represent standard deviation.
To test whether such protection of DNA from serum is effective in PBK10-mediated gene delivery, complexes were formed with increasing concentrations of protamine, and then exposed to HeLa cell monolayers in the presence or absence of 1% serum. It is evident by microscopy that the addition of protamine alone to DNA fails to produce GFP-positive cells (Figure 3e and f) , suggesting that DNA condensation by protamine alone is not enough to produce high levels of gene delivery. However, the addition of protamine to PBK10-bound complexes enhances GFP expression by many-fold (Figure 3g and h), indicating that PBK10 is still required for efficient delivery. More importantly, there is little difference in GFP expression in the presence or absence of serum ( Figure 5b and Table 1 ), indicating that protamine protects against serum-mediated inactivation of gene delivery. This suggests that the predominant factor inhibiting PBK10-mediated gene delivery seen in Figure 4b is the access of DNA to degradative nucleases found in serum.
PBK10-mediated gene delivery is specific Adding 1, 5 and 10 g of protamine to constant amounts of plasmid produces negligible levels of GFP expression Gene Therapy
Figure 6 Specificity of PBK10-mediated gene delivery. DNA (3.5 g), protamine, and/or penton proteins are mixed and exposed to HeLa cells as described. (a) GFP expression is measured from cells treated with protamine condensed DNA (white bars), PBK10/protamine/DNA (striped bars), or PBrgdK10/protamine/DNA (gray bars). (b) Gene delivery and GFP expression in the presence of competing amounts of RGD peptide. GFP expression is measured from cells treated with protamine-condensed DNA (dotted line), or PBK10/protamine/DNA (solid line). Experiments were performed in triplicate, and relative transduction was determined by the percent of GFP-positive cells of treated cell populations over untreated cells. Error bars represent standard deviation.
( Figure 6a , white bars), whereas adding PBK10 to all three protamine concentrations greatly enhances green fluorescence (Figure 6a, striped bars) . The optimal ratios of PBK10 to protamine, however, determine the degree to which fluorescence is enhanced. Numerous studies show that a neutral to net positive charge promotes high cellular transfection of DNA complexes, presumably by preventing repulsion of DNA from negatively charged cell surface proteins. 46 It is demonstrated here, however, that PBK10 contributes more than mere charge neutralization to enhance gene delivery. At 1 g concentrations of both PBK10 and protamine, the theoretical charge ratio (cations to DNA phosphates) is less than 1, yet PBK10 + protamine enhances GFP expression 52-fold higher than protamine alone (Figure 6a ). GFP expression is enhanced an additional 2.6-fold by the inclusion of 5 g of protamine with PBK10, which adds enough cations to theoretically neutralize all of the plasmid (Figure 6a ). Excess protamine, however, is expected to reduce delivery if protamine competes with PBK10 for DNA binding. In agreement with this expectation, GFP expression is reduced 2.7-fold when PBK10 is incubated with 10 g of protamine compared to 5 g, despite the fact that there is a theoretical net positive charge. Nevertheless, at 10 g Gene Therapy of protamine, GFP expression is still four-fold higher in the presence of PBK10 over protamine alone (Figure 6a ). These results demonstrate that whereas charge neutralization is an important contributing factor for gene delivery, PBK10 is required for promoting high levels of delivery, presumably by directing the complexes to cellular receptors.
To confirm indeed that integrin receptor binding and endocytosis mediates cellular entry of the complexes described here, the RGD sequence of penton was mutated to produce a defective integrin binding site. The amino acid replacement, R340E, has been shown by others to severely reduce integrin-binding activity 36 and was, therefore, introduced here to produce the mutant penton, PBrgdK10. This mutant protein was tested for DNA binding activity by DNA mobility shift analysis (Figure 2b ). PBrgdK10 produces similar plasmid retardation patterns as PBK10 by this assay, indicating that the mutation does not appear to impede DNA binding activity. Gene delivery by PBrgdK10 was tested on HeLa cells under the same conditions as described earlier. GFP expression is reduced to undetectable levels by PBrgdK10 compared to equivalent concentrations of PBK10 ( Figure  6a , gray bars). Inclusion of 1 and 5 g concentrations of protamine to PBrgdK10 complexes does not improve GFP expression. At 10 g of protamine, GFP expression is enhanced only slightly, but remains 2.7-fold lower compared with the same concentration of protamine + PBK10.
Others have demonstrated that specific RGD-containing peptides interfere with penton binding to ␣ v integrins. 37 Similar peptides are used here, therefore, to provide further confirmation of specificity. A 300-fold molar excess of RGD-peptide to PBK10 reduces GFP expression by approximately 70% (Figure 6b, solid line) . As protamine-mediated delivery comprises р10% of the GFP expression (Figure 6b , dotted line), LDV-mediated binding and internalization may account for the residual delivery. Taken together, these findings provide evidence that PBK10 directs the complexes to HeLa cells predominantly through the integrin-binding motif, RGD.
Discussion
The utility of adenovirus capsid proteins for enhancing cell permeability has been implicated in previous studies. Co-administration of adenovirus with transferrinmediated internalization of plasmid DNA resulted in enhanced plasmid gene expression, suggesting that adenoviral proteins promoted endosomal escape. 19 Direct conjugation of heat inactivated adenovirus to transferrin conjugates confirmed that adenovirus capsid proteins mediated the evasion of lysosomal degradation. 20, 21 More recently, it has been shown that the penton protein alone is capable of enhancing vesicle lysis and could mediate the escape of plasmid DNA from endosomes. 36, 47 Our data confirm that the penton possesses the capacity for translocation across cell membranes by direct linkage of a marker plasmid to the polylysine tract of PBK10 and subsequent expression of the marker gene in treated cells.
It has been shown that the 'dodecahedra' formed by Ad3 pentons are sufficient for endosome penetration and, when assembled with synthetic cationic peptides, can mediate cellular internalization of DNA. 47 Although the cavity formed by a 'dodecahedron' is too small to be occupied by plasmid DNA, the coating of these particles with cationic residues allows DNA binding over the surface of the molecule. In contrast, the placement of cationic residues at one end of the penton peptide sequence as described here presumably allows DNA binding at a localized region of the protein, with the intention of coating the DNA with penton protein molecules, rather than the other way around.
Protamine was found to enhance PBK10-mediated gene delivery in the presence of serum, presumably by protecting PBK10-bound DNA from serum nucleases. However, excess protamine reduces gene delivery. This is likely due to the competition of higher protamine with PBK10 for binding DNA. Therefore, the optimized ratios of PBK10/protamine/DNA that were chosen provide both protection from serum and efficient gene delivery. We name these PBK10/protamine/DNA complexes '3PO'.
Gene delivery by 3PO can be compared with that mediated by a recombinant adenovirus expressing GFP (Ad5-GFP). At 100 pmoles of PBK10 (approximately 10 9 3PO complexes), transduction efficiency of HeLa cells, as measured by GFP expression, is comparable to that of approximately 5 × 10 6 viral particles (data not shown). On the other hand, approximately 10 9 viral particles are required to obtain similar levels of infection of HUVEC cells, which lack CAR, but express ␣ v ␤ 3 integrins. 48 This suggests that viral entry mediated by penton-integrin binding is 1000-fold less efficient than that mediated by fiber-CAR interaction. Thus, it seems that the 3PO complexes are as efficient in DNA delivery as adenoviruses in the absence of CAR receptors. It will be interesting to see, therefore, whether the transduction efficiency by 3PO will be enhanced by the addition of fiber protein. The optimized 3PO complexes described here contain, theoretically, 90 molecules of PBK10 per plasmid DNA. Interestingly, this number closely coincides with the number of pentons assembled per Ad5 capsid (60 pentons/ capsid).
There are several advantages to using the penton capsid protein as opposed to the whole virus for gene delivery. One is that the size of the delivered gene is not constrained by a viral capsid, making this system flexible enough to accommodate potentially any size gene. Previous studies have shown that the use of a polylysine moiety binds to a wide range of nucleic acid sizes, from 564 base pairs to 48 kilobases, thus it is conceivable that the vector system presented here may accommodate a comparable range of gene sizes. 1, 20 Additionally, 3PO complexes might have an advantage in delivery to tissues that lack CAR, as they will not be sequestered by CARexpressing cells. Although the adenovirus capsid elicits a neutralizing immune response, 49, 50 its efficient cell entry mechanism remains a desirable feature for gene delivery to both dividing and nondividing cells. A vector containing only the penton protein as opposed to the whole capsid is expected to elicit a much less potent immune response in comparison to the whole virus. It has been well established that de novo synthesis of viral proteins after infection produces a cytolytic T cell response to infected cells. [50] [51] [52] [53] [54] [55] [56] However, lack of all viral genes and other structural proteins should greatly minimize both the immunogenicity and toxicity of these vectors compared with current adenoviral vectors. In addition, protein-based delivery avoids many concerns associated with using virus vectors, such as potential viral recombination. Finally, these 3PO complexes make use of the best features of the adenovirus capsid for efficient cell binding and internalization, while avoiding the need to produce high titers of actual virus.
Materials and methods
Cells, plasmids and peptides 293 and HeLa cells were maintained in DMEM, 10% fetal bovine serum, at 37°C, 5% CO 2 . The reporter plasmid, pGFPemd-cmv [R] control vector (Packard Instrument Company, Meriden, CT, USA), was used for gene delivery assays. The RGD-containing peptide (GRGDTP) was obtained from Sigma.
DNA constructs
A common 5Ј oligonucleotide primer containing the sequence 5Ј-ATCGAAGGATCCATGCGG CGCGCGGCG ATGTAT-3Ј was used to amplify both wild-type and lysine-tagged penton sequences from a pJM17 adenoviral genome template. The sequences of the 3Ј primers are 5Ј-GCATCAGAATTCTCAAAAAGTGCGGCTCGATAG-3Ј (wild-type penton) and 5Ј-CATGAATTCATTTTTTT TTTTTTTTTTTTTTTTTTTTTTTAAAAGTGCGGCTCGA-TAGGA-3Ј (lysine-tagged penton). A BamHI restriction site was introduced in the 5Ј primer and an EcoRI restriction site was introduced in the 3Ј primers for in-frame insertion of both the wild-type and lysine-tagged pentons into the pRSET-A bacterial expression plasmid (Invitrogen, Carlsbad, CA, USA). This plasmid expresses the recombinant protein as an N-terminally histidinetagged fusion for affinity purification by nickel chelate affinity chromatography.
Protein expression and purification from bacteria Overnight cultures of BL21(DE3)pLysS (Novagen, Madison, WI, USA) bacterial transformants were innoculated 1:50 in LB containing 0.1 mg/ml ampicillin and 0.034 mg/ml chloramphenicol. At OD 600 ෂ0.6, cultures were induced with 1 mm IPTG and grown 4 more h at 37°C with shaking. Cultures were harvested and pelleted. Cell pellets were resuspended in lysis buffer (50 mm Na-phosphate, pH 8.0; 500 mm NaCl; 5-10 mm imidazole; 1 mm phenylmethylsulfonyl fluoride) and lysed by addition of 0.1% Triton X-100 and one cycle of freeze-thawing. Supernatants were recovered, added to Ni-NTA resin (Qiagen, Valencia, CA, USA) pre-equilibrated in lysis buffer, and incubated for 1 h on ice. The resin containing bound protein was washed with 10 ml of lysis buffer, then 6 ml of a solution of 50 mm Na-phosphate, pH 8.0; 500 mm NaCl; 60 mm imidazole, and protein was eluted with 2 ml of a solution of 50 mm Na-phosphate, pH 8.0; 500 mm NaCl; 400 mm imidazole. Proteins were desalted on YM-10 nominal molecular weight limit spin columns (Millipore, Bedford, MA, USA) and their concentrations measured using the BioRad protein quantitation assay.
Protein detection
Denaturing and nondenaturing polyacrylamide gel electrophoresis was performed in a discontinuous gel buffer system as previously described. 57 Nondenaturing gel electrophoresis differed by eliminating SDS from gels, running buffer, and sample buffer, and by not boiling the samples before electrophoresis. Proteins were electrically transferred on to nitrocellulose using 39 mm glycine, 48 mm Tris-HCl, 0.0375% SDS, 20% methanol in a BioRad semi-dry transfer cell set at constant voltage (15 V) for 30 min. Blots were blocked with 3% milk in PBS. Anti-His Tag antisera (Sigma, St Louis, MO, USA) was used at a 1:3000 dilution in blocking buffer. Anti-Ad5 antisera (Access Bio Medical, San Diego, CA, USA) was used at a 1:8000 dilution in blocking buffer. Antibody-antigen complexes were detected by incubation with horseradish peroxidase (HRP) conjugated secondary antibodies (Sigma), reaction with chemiluminescence detection reagents, and exposure to film (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Cell binding assay Cells were treated with GFP-tagged proteins as described elsewhere. 42 Briefly, 293 cells grown to 75% confluency were lifted with phosphate-buffered saline (PBS) supplemented with 2 mm EDTA, centrifuged, washed, then added to PBS containing GFP-tagged proteins and 3% milk to reduce non-specific binding. After a 1 h incubation on ice, cells were centrifuged, washed thoroughly, resuspended in 0.5 ml PBS and measured by FACS scan.
DNA mobility shift assays A nonspecific oligonucleotide sequence (30 nucleotides) served as a nucleic acid probe for testing the electrostatic coupling of the lysine-tagged penton to nucleic acids. The oligonucleotide was radiolabelled with gamma (32P)dATP using the forward reaction enzyme activity of T4 kinase (Life Technologies, Rockville, MD, USA) following standard protocol, and unincorporated label was removed using a Nucleotide Purification Kit (Qiagen). Various concentrations of protein and oligonucleotide probe were incubated together in 15 l total volumes in the presence of HEPES-buffered saline (HBS; 150 mm NaCl, 20 mm HEPES, pH 7.3) for 30 min at room temperature. Five microliters of sample dye (30% glycerol in water and bromophenol blue) were added, then each reaction was loaded on to a 5% polyacrylamide vertical gel pre-run in 1 × tris-glycine buffer for 20 min. The gel was run at room temperature at about 180 V for approximately 2 h. For the plasmid mobility shift assay, plasmid DNA was mixed with proteins at the indicated ratios in HBS for 30 min at room temperature in a total volume of 10 l. After incubation, 2 l of sample dye was added to the mixtures, mixes were loaded on a 0.8% agarose gel, and electrophoresed at 50 V. Gels were stained with ethidium bromide after electrophoresis to visualize DNA bands.
DNA protection assay
Plasmid and proteins were added together at various ratios in a total volume of 20 l and incubated at room temperature for 30 min. Four microliters of active (nonheat inactivated) fetal bovine serum were added to each mix and mixtures were incubated at 37°C. SDS at a 1% final concentration was added to each mix to release the proteins from the DNA. Four microliters of sample dye was added to each mix, and mixtures were electrophoresed on agarose gels as described earlier.
Cell delivery assays
Cells were grown on 24-well dishes to approximately 75% confluency. Proteins and plasmids (3.5 or 5 g) were incubated together at various ratios at room temperature for 30 min in 0.3 ml of adhesion buffer (DMEM, 2 mm MgCl 2 , 20 mm HEPES), then added to cell monolayers. Cells were exposed to mixes for 3-5 h at 37°C, 5% CO 2 , before the addition of complete serum. For FACS analysis, cells were trypsinized 3 days after treatment, centrifuged at 500 g, and resuspended in 0.5 ml of phosphate buffered saline (PBS). In other assays, cells were trypsinized and counted using a hemocytometer under UV light microscopy to determine the percentage and absolute numbers of GFP-positive cells.
UV microscopy
An Olympus (Lake Success, NY, USA) IMT-2 inverted microscope fitted with an FITC filter was used to visualize GFP-positive cells. Photomicrographs were taken at 4 × and 10 × magnification.
FACS analysis
Where indicated, 5000-10 000 events are counted on a Becton Dickinson FAC Scan analyzer (Becton Dickinson, Franklin Lakes, NJ, USA) using a 15 mW air-cooled argon laser set at 488 nm and recorded with a 530 nm emission filter in the FL1 emission channel. Cell populations are represented on a FACS histogram plotting green fluorescence intensity on a logarithmic scale against cell number. Fluorescence intensity of cell populations is indicated by a shift to the right of the histographical plots of treated cells. Fluorescence enhancement was determined by obtaining the number of gated fluorescent events for untreated and treated cells.
